Retinal Gene Therapy: Bridging the Gap

DSpace Repository

Show simple item record

dc.contributor.advisor Fischer, M. Dominik (Prof. Dr.) Seitz, Immanuel Philipp 2022-03-11T10:21:35Z 2022-03-11T10:21:35Z 2022-03-11
dc.identifier.uri de_DE
dc.description.abstract After 50 years of gradual progress, the last decade has seen gene therapy shaping up to be a transformational technology for the treatment of previously untreatable monogenetic disorders. After being set back by several decades, crucial improvements to vector safety have again propelled gene augmentation therapy into translational reality, with monogenetic retinal disorders on the forefront of the development. This dissertation aimed to inform translational efforts towards Germany's first ocular gene therapy trials, which were conducted at the Centre for Ophthalmology in Tübingen. The individual chapters discuss the candidate's work along a trajectory from pre-clinical to clinical stages of these trials. It starts with the analysis and interpretation of comprehensive findings regarding patient, germline, and environmental safety of gene augmentation therapy, gathered from non-human primates, which led to important new hypotheses, regarding vector development and delivery, as well as patient management. Moving closer to Germany's first ocular gene therapy surgery, the thesis presents a careful, multi-modal analysis of Choroideremia patients' phenotypes, that factored into subject selection, validated the trial design, and helped to further define this rare disease. Spurred by the challenge to define novel clinical endpoints, and based on the phenotype, which was characterized in the second section, this work concludes with the investigation of a recent, computer-based colour vision test in treatment candidates, to establish its adequacy as an endpoint in retinal gene therapy trials. This dissertation is complemented by multiple reviews regarding inherited retinal disorders, as well as multiple second- and co- authorships in related literature. In its entirety, this thesis aims to paint a comprehensive picture of translational efforts in the dawn of potentially transformational advances in gene therapy. en
dc.language.iso en de_DE
dc.publisher Universität Tübingen de_DE
dc.rights ubt-podok de_DE
dc.rights.uri de_DE
dc.rights.uri en
dc.subject.ddc 610 de_DE
dc.subject.other Ophthalmologie de_DE
dc.subject.other Gentherapie de_DE
dc.subject.other gene therapy en
dc.subject.other Ophthalmology en
dc.title Retinal Gene Therapy: Bridging the Gap en
dc.type PhDThesis de_DE
dcterms.dateAccepted 2022-01-26
utue.publikation.fachbereich Medizin de_DE
utue.publikation.fakultaet 4 Medizinische Fakultät de_DE
utue.publikation.noppn yes de_DE


This item appears in the following Collection(s)

Show simple item record